Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)
Side effects can vary among individuals, and some may experience none
Key Takeaways Out of 544 BPC-157 studies everyone cites, only one was actually done in humans one
Witters LA
US$ 23.71
US$ 28.34
US$ 26.61
US$ 20.75
US$ 24.52
